Flucanazole Injection, USP 200 mg in in 100 mL (2 mg/mL), 10 Single Dose Flexible Containers, Rx Only, Manufactured for: Claris Lifesciences, Inc. North Brunswick, NJ 08902 By; Claris Injectables Ltd. Gujarat, India --- NDC 36000-006-10
Published April 4, 2018 · Recall initiated: March 2, 2018
Summary
FDA records drug Class III recall D-0605-2018, published April 4, 2018 and initiated March 2, 2018. Recalling firm: Renaissance Lakewood, LLC; Status: Terminated; Reported quantity: 1277 bags; Lot: Lot A060644, May 2018. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Superpotent and Failed Stability Specifications; out of specification results for assay and water vapor permeability
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Renaissance Lakewood, LLC
- Distributor
- Nationwide
- Lot
- Lot A060644, May 2018
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFluconazole Injection, USP, Iso-Osmotic Sodium Chloride Diluent, 200 mg in 100 mL (2 mg/mL), 100 mL SingleAugust 8, 2018
- FDAFluconazole Injection, USP, Iso-Osmotic Sodium Chloride Diluent, 400 mg in 200 mL (2 mg/mL), 200 mL SingleAugust 8, 2018
- FDAFluconazole Injection, USP, Iso-Osmotic Sodium Chloride Diluent, 200 mg in 100 mL (2 mg/mL), package in 100 mLApril 25, 2018
- FDAIndomethacin Capsules USP, 50 mg, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd.,April 4, 2018
- FDAARROWg+ard Blue PLUS Pressure Injectable Multi-Lumen CVC Kit. Intended to permit venous access to the centralMarch 28, 2018
- FDAFluconazole Injection, USP, 2 mg/mL, a) 50 mL (NDC 336000-261-10) and b) 100 mL (NDC 33600-002-10), Rx Only,December 27, 2017
Questions about this recall
Was Flucanazole Injection, USP 200 mg in in 100 mL (2 mg/mL), 10 Single Dose Flexible Containers, Rx Only, Manufactured for: Claris Lifesciences, Inc. North Brunswick, NJ 08902 By; Claris Injectables Ltd. Gujarat, India --- NDC 36000-006-10 recalled?
Yes. FDA published recall D-0605-2018 on April 4, 2018. Reported hazard: Superpotent and Failed Stability Specifications; out of specification results for assay and water vapor permeability
What should I do if I have this product?
Voluntary: Firm initiated · Letter